Global Hematology Analyzers Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028
“Global Hematology Analyzers Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global hematology analyzers market report has been segmented on the basis of number of parameters, end user, and region.
Global Hematology Analyzers Market: Overview
Worldwide there is a continuous increase in various new diseases and disorders. Hematology analyzers assist in the diagnosis of various diseases such as viruses, infections, cancer, etc. These devices are made of various analytical modules and are able to control drug level in both illegal drugs and therapeutic drugs. The major end users of these devices are research institutes and hospitals. Hematology analyzers nowadays are available with an integrated reticulocyte count analysis with routine complete blood count analysis.
Global Hematology Analyzers Market: Dynamics
Rising incidences of chronic diseases across the globe and increase demand for hematology analyzers by hospitals in order to enhance laboratory operations and improve patient care are major factors expected to drive growth of the global market.
Continuous technological advancements in laboratory devices, rapid innovation/advancements in the medical sector in areas such as genetic therapies, pharmacogenomics, bleeding disorders, stem cell research, and proteomics, coupled with rising awareness related to medical availability of advanced medical devices are among other factors expected to support market growth.
Moreover, increasing government expenditure on the healthcare sector, rising preferences towards high sensitivity hematology testing, and introduction of basic cytometry techniques analyzers are among other factors.
However, high-cost of hematology analyzers is a major factor expected to hamper growth of the global market. In addition, high time-consumption for results and stringent regulatory scenarios for product approval are among other factors expected to challenge market growth.
Technological advancements and R&D activates by major players and product innovation such as the expansion of high throughput hematology analyzers are factors expected to create new opportunities in terms of revenue for players operating in the target market over the forecast period. In addition, growing public-private partnership for the development of innovative products is expected to further support market growth.
Global Hematology Analyzers Market: Segment
Among the number of parameters segments, the up to 10 parameters segment is expected to dominate in the target market over the forecast period.
Among the end user segments, the stand-alone hospital's segment is expected to dominate in the target market over the forecast period.
Global Hematology Analyzers Market: Region
The market in North America and Europe are expected to contribute significant revenue shares in the global market. This can be attributed to the increasing number of outpatients in hospitals and clinics suffering from various diseases, availability of advanced devices and favorable policies, and the presence of major players operating in the countries in this region. In addition, growing merger and acquisition activities between regional and international players are expected to further support the market growth in this region.
The market in Asia Pacific is expected to witness faster growth, owing to increasing government spending on the healthcare sector and the presence of prominent players operating in emerging economies in this region.
Global Hematology Analyzers Market Segmentation:
Segmentation by number of parameters
- Up to 10 Parameters
- 10-30 Parameters
- Above 30 Parameters
Segmentation by end-users
- Stand-alone hospitals
- Clinical testing labs
- Research institutes
- Commercial organizations
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Sysmex Corporation
- Beckman Coulter, Inc.
- Abbott Laboratories
- Siemens Healthcare
- Bayer AG
- HORIBA ABX SAS
- ASL Industries Limited
- Boule Diagnostics AB
- Research and Production Complex “Biopromin” Ltd.
- Mindray Medical International Limited
- Sinnowa Medical Science & Technology Co., Ltd.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!